Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

ModusLink Global Solutions, Inc. (MLNK) Forges Collaborative Agreement with PagBrasil, Expands e-Commerce Support to Brazil

Posted on September 13, 2012 by MissionIR

ModusLink Global Solutions has announced a collaboration with PagBrasil to provide e-commerce transaction support in Brazil. Payment options and tax issues are complex in that country, but with this new agreement ModusLink will be able to provide its e-commerce customers … Continue reading →

Posted in Small Cap News | Leave a comment

Vimicro International Corp. (VIMC) Enters Joint Venture in Shanxi Province to Expand Security-Surveillance Business

Posted on September 12, 2012 by MissionIR

Vimicro International said today it has entered a joint venture with Shanxi Guoxin Investment Corp. (“Guoxin Group”) to form a subsidiary that will make and sell Surveillance Video and Audio Coding (“SVAC”) based security products along with related intelligence and … Continue reading →

Posted in Small Cap News | Leave a comment

Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061

Posted on September 12, 2012 by MissionIR

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. One such product in the company’s pipeline is TO-2061, a drug to be used … Continue reading →

Posted in Small Cap News | Leave a comment

Altairnano, Inc. (ALTI) and Shenhua Science & Technology Sign Memorandum of Understanding

Posted on September 12, 2012 by MissionIR

It was recently announced that an agreement was signed by three parties to develop, deploy, and promote industrial applications of lithium titanate-based energy storage systems in China. Altairnano, Shenhua Science & Technology (Shenhua S&T) and its research affiliate, and the … Continue reading →

Posted in Small Cap News | Leave a comment

Gilat Satellite Networks Ltd. (GILT) Subsidiary Installs VSAT Technology in 10,000th Dollar General Store

Posted on September 12, 2012 by MissionIR

Gilat Satellite Networks, a global leader in satellite networking technology, solutions, and services, announced today that Spacenet, Inc., a wholly owned subsidiary of Gilat and prominent provider of managed network and data security services, has equipped its 10,000th Dollar General … Continue reading →

Posted in Small Cap News | Leave a comment

SFDA Approval Granted for Dehaier Medical Ltd. (DHRM) DHR-CPAP-C5 Device for Treating Sleep Apnea

Posted on September 12, 2012 by MissionIR

Dehaier Medical Systems announced that it has obtained State Food and Drug Administration approval for DHR-CPAP-C5, one of the company’s primary proprietary homecare medical devices. The validity period for the SFDA approval is four years. Continuous positive airway pressure (CPAP) … Continue reading →

Posted in Small Cap News | Leave a comment

Lexicon Pharmaceuticals, Inc. (LXRX) Video Chart for Wednesday, September 12, 2012

Posted on September 12, 2012 by MissionIR

LXRX has been holding a steady uptrend throughout 2012. After a recent pullback from highs of $3.28, the chart is on the incline again and testing the 50-day moving average as the indicators show a strengthening trend and momentum. Technical … Continue reading →

Posted in Technical Analysis | Leave a comment

Extensive Medical Industry Experience Links Cardium Therapeutics, Inc. (CXM) Management Team

Posted on September 12, 2012 by MissionIR

Cardium Therapeutics, a San Diego based health sciences and regenerative medicine company, is focused on the acquisition and development of new and innovative bio-medical product opportunities and businesses offering the potential of addressing significant unmet medical needs, and which also … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Adherex Technologies, Inc. (AHX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Posted on September 11, 2012 by Mission IR

Adherex Technologies, a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics, aims to increase the longevity and improve the quality of life for cancer patients. The company is developing Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

NeuroMetrix, Inc. (NURO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Posted on September 11, 2012 by Mission IR

NeuroMetrix is a medical device company that develops and markets home use and point-of-care devices, associated consumables, and support software for the treatment and management of diabetes and its complications. The company markets the NC-stat® DPNCheck™ device, which is used … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment